TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Dienstmann, R. AU - Mason, M. J. AU - Sinicrope, F. A. AU - Phipps, A. I. AU - Tejpar, S. AU - Nesbakken, A. PY - 2017 DA - 2017// TI - Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx052 DO - 10.1093/annonc/mdx052 ID - Dienstmann2017 ER - TY - JOUR AU - Naxerova, K. AU - Reiter, J. G. AU - Brachtel, E. AU - Lennerz, J. K. AU - Wetering, M. AU - Rowan, A. PY - 2017 DA - 2017// TI - Origins of lymphatic and distant metastases in human colorectal cancer JO - Science (New York, NY) VL - 357 UR - https://doi.org/10.1126/science.aai8515 DO - 10.1126/science.aai8515 ID - Naxerova2017 ER - TY - JOUR AU - Guinney, J. AU - Dienstmann, R. AU - Wang, X. AU - Reynies, A. AU - Schlicker, A. AU - Soneson, C. PY - 2015 DA - 2015// TI - The consensus molecular subtypes of colorectal cancer JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3967 DO - 10.1038/nm.3967 ID - Guinney2015 ER - TY - JOUR AU - Marisa, L. AU - Reynies, A. AU - Duval, A. AU - Selves, J. AU - Gaub, M. P. AU - Vescovo, L. PY - 2013 DA - 2013// TI - Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001453 DO - 10.1371/journal.pmed.1001453 ID - Marisa2013 ER - TY - JOUR AU - Kloosterman, W. P. AU - Braak RRJ, C. AU - Pieterse, M. AU - Roosmalen, M. J. AU - Sieuwerts, A. M. AU - Stangl, C. PY - 2017 DA - 2017// TI - A systematic analysis of oncogenic gene fusions in primary Colon Cancer JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-3563 DO - 10.1158/0008-5472.CAN-16-3563 ID - Kloosterman2017 ER - TY - JOUR AU - Sousa, E. M. F. AU - Wang, X. AU - Jansen, M. AU - Fessler, E. AU - Trinh, A. AU - Rooij, L. P. PY - 2013 DA - 2013// TI - Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3174 DO - 10.1038/nm.3174 ID - Sousa2013 ER - TY - JOUR AU - Benson, A. B. AU - Schrag, D. AU - Somerfield, M. R. AU - Cohen, A. M. AU - Figueredo, A. T. AU - Flynn, P. J. PY - 2004 DA - 2004// TI - American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.063 DO - 10.1200/JCO.2004.05.063 ID - Benson2004 ER - TY - JOUR AU - Andre, T. AU - Gramont, A. AU - Vernerey, D. AU - Chibaudel, B. AU - Bonnetain, F. AU - Tijeras-Raballand, A. PY - 2015 DA - 2015// TI - Adjuvant fluorouracil, Leucovorin, and Oxaliplatin in stage II to III Colon Cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.4238 DO - 10.1200/JCO.2015.63.4238 ID - Andre2015 ER - TY - JOUR AU - Cakar, B. AU - Varol, U. AU - Junushova, B. AU - Muslu, U. AU - Gursoy Oner, P. AU - Gokhan Surmeli, Z. PY - 2013 DA - 2013// TI - Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer JO - J BUON VL - 18 ID - Cakar2013 ER - TY - JOUR AU - Jalaeikhoo, H. AU - Zokaasadi, M. AU - Khajeh-Mehrizi, A. AU - Rajaeinejad, M. AU - Mousavi, S. A. AU - Vaezi, M. PY - 2019 DA - 2019// TI - Effectiveness of adjuvant chemotherapy in patients with stage II colorectal cancer: a multicenter retrospective study JO - J Res Med Sci VL - 24 UR - https://doi.org/10.4103/jrms.JRMS_106_18 DO - 10.4103/jrms.JRMS_106_18 ID - Jalaeikhoo2019 ER - TY - JOUR AU - Kumar, A. AU - Kennecke, H. F. AU - Renouf, D. J. AU - Lim, H. J. AU - Gill, S. AU - Woods, R. PY - 2015 DA - 2015// TI - Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer JO - Cancer. VL - 121 UR - https://doi.org/10.1002/cncr.29072 DO - 10.1002/cncr.29072 ID - Kumar2015 ER - TY - JOUR AU - O'Connor, E. S. AU - Greenblatt, D. Y. AU - LoConte, N. K. AU - Gangnon, R. E. AU - Liou, J. I. AU - Heise, C. P. PY - 2011 DA - 2011// TI - Adjuvant chemotherapy for stage II colon cancer with poor prognostic features JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.34.3426 DO - 10.1200/JCO.2010.34.3426 ID - O'Connor2011 ER - TY - JOUR AU - Nagtegaal, I. D. AU - Schmoll, H. J. PY - 2017 DA - 2017// TI - Colorectal cancer: what is the role of lymph node metastases in the progression of colorectal cancer? JO - Nat Rev Gastroenterol Hepatol VL - 14 UR - https://doi.org/10.1038/nrgastro.2017.122 DO - 10.1038/nrgastro.2017.122 ID - Nagtegaal2017 ER - TY - JOUR AU - Ghajar, C. M. AU - Bissell, M. J. PY - 2016 DA - 2016// TI - Metastasis: Pathways of parallel progression JO - Nature VL - 540 UR - https://doi.org/10.1038/nature21104 DO - 10.1038/nature21104 ID - Ghajar2016 ER - TY - JOUR AU - Mekenkamp, L. J. AU - Koopman, M. AU - Teerenstra, S. AU - Krieken, J. H. AU - Mol, L. AU - Nagtegaal, I. D. PY - 2010 DA - 2010// TI - Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases JO - Br J Cancer VL - 103 UR - https://doi.org/10.1038/sj.bjc.6605737 DO - 10.1038/sj.bjc.6605737 ID - Mekenkamp2010 ER - TY - STD TI - Rahbari NN, Carr PR, Jansen L, Chang-Claude J, Weitz J, Hoffmeister M, et al. Time of metastasis and outcome in colorectal cancer. Ann Surg. 2019;269(3):494-502. ID - ref17 ER - TY - JOUR AU - Pool, A. E. AU - Lalmahomed, Z. S. AU - Ozbay, Y. AU - Wilt, J. H. AU - Eggermont, A. M. AU - Jzermans, J. N. PY - 2010 DA - 2010// TI - ‘Staged’ liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome JO - Colorectal Dis VL - 12 UR - https://doi.org/10.1111/j.1463-1318.2009.02135.x DO - 10.1111/j.1463-1318.2009.02135.x ID - Pool2010 ER - TY - JOUR AU - Des Guetz, G. AU - Schischmanoff, O. AU - Nicolas, P. AU - Perret, G. Y. AU - Morere, J. F. AU - Uzzan, B. PY - 2009 DA - 2009// TI - Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2009.04.018 DO - 10.1016/j.ejca.2009.04.018 ID - Des Guetz2009 ER - TY - JOUR AU - Sargent, D. J. AU - Marsoni, S. AU - Monges, G. AU - Thibodeau, S. N. AU - Labianca, R. AU - Hamilton, S. R. PY - 2010 DA - 2010// TI - Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.1825 DO - 10.1200/JCO.2009.27.1825 ID - Sargent2010 ER - TY - JOUR AU - Le, D. T. AU - Uram, J. N. AU - Wang, H. AU - Bartlett, B. R. AU - Kemberling, H. AU - Eyring, A. D. PY - 2015 DA - 2015// TI - PD-1 blockade in tumors with mismatch-repair deficiency JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1500596 DO - 10.1056/NEJMoa1500596 ID - Le2015 ER - TY - JOUR AU - Lenz, H. J. AU - Ou, F. S. AU - Venook, A. P. AU - Hochster, H. S. AU - Niedzwiecki, D. AU - Goldberg, R. M. PY - 2019 DA - 2019// TI - Impact of consensus molecular subtype on survival in patients with metastatic colorectal Cancer: results from CALGB/SWOG 80405 (Alliance) JO - J Clin Oncol VL - 37 UR - https://doi.org/10.1200/JCO.18.02258 DO - 10.1200/JCO.18.02258 ID - Lenz2019 ER - TY - JOUR AU - Trinh, A. AU - Trumpi, K. AU - Sousa, E. M. F. AU - Wang, X. AU - Jong, J. H. AU - Fessler, E. PY - 2017 DA - 2017// TI - Practical and robust identification of molecular subtypes in colorectal Cancer by immunohistochemistry JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0680 DO - 10.1158/1078-0432.CCR-16-0680 ID - Trinh2017 ER - TY - JOUR AU - Roepman, P. AU - Schlicker, A. AU - Tabernero, J. AU - Majewski, I. AU - Tian, S. AU - Moreno, V. PY - 2014 DA - 2014// TI - Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition JO - Int J Cancer VL - 134 UR - https://doi.org/10.1002/ijc.28387 DO - 10.1002/ijc.28387 ID - Roepman2014 ER - TY - JOUR AU - Song, N. AU - Pogue-Geile, K. L. AU - Gavin, P. G. AU - Yothers, G. AU - Kim, S. R. AU - Johnson, N. L. PY - 2016 DA - 2016// TI - Clinical outcome from Oxaliplatin treatment in stage II/III Colon Cancer according to intrinsic subtypes: secondary analysis of NSABP C-07/NRG oncology randomized clinical trial JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2016.2314 DO - 10.1001/jamaoncol.2016.2314 ID - Song2016 ER -